Understanding these alterations is crucial for advancing our knowledge of HCC pathogenesis and may inform future therapeutic strategies tailored to the distinct molecular characteristics of mid-lobular hepatocytes in the context of AEG-1 mutations. The gene discussed is MTDH; the disease is hepatocellular carcinoma.